THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry.

Pierre Henri GabrielleVuong NguyenCatherine Creuzot-GarcherJennifer J ArnoldHemal MehtaMónica Asencio DuranWalid BougamhaEster CarreñoFrancesco ViolaDavid SquirrellDaniel BarthelmesMark Gillies

Published in: Retina (Philadelphia, Pa.) (2022)

Aflibercept and ranibizumab were both effective and safe for diabetic macular edema over 3 years.

Keyphrases

age related macular degeneration
diabetic retinopathy
optical coherence tomography
electronic health record
big data
optic nerve